More on Dendreon earnings


Dendreon (DNDN) Q2 misses on all counts

The company notes that the competitive environment remains largely unchanged from the first quarter.

Based upon current enrollment trends in July and August, it doesn't expect to see enough of a sales increase in H2 to meet its goal of growing Provenge Y/Y.

The company currently has $280.6M in cash, cash equivalents, and short-term and long-term investments, compared to $429.8M as of December 31, 2012.

Shares -12% AH.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs